Trial intelligence / Profile preview

Lidocaine versus lidocaine plus ketamine hematoma block for pain control during distal radius fracture reduction

IRCT20200622047874N2Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in distal forearm fracture comparing Lidocaine hematoma block with Lidocaine plus ketamine hematoma block (2 arms). Primary endpoints: Pain severity during reduction and Patient satisfaction. Started Aug 2021; status: completed.

02

Drugs

lidocaineketamine
03

Conditions

distal forearm fracture

Beyond the preview

Go deeper on IRCT20200622047874N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200622047874N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call